Delivery Order SPE2DR25D3202-SPE2DR26F8D7T
- Not listed
- The Defense Logistics Agency awarded a $1,633.77 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The contract employs firm...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,581.94 for PREVNAR 20 vaccine in 0.5 mL syringes, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine will...
- The Defense Logistics Agency awarded a delivery order valued at $13,607.68 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,633.77 delivery order contract to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevnar 20 syringes (0.5mL). This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The contract requires fulfillment by August 20, 2025, with performance at...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.10 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency has awarded a delivery order valued at $7,128.81 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5 mL) with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on June 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order serves as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.94 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $9,802.68 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) on January 29, 2025, with an ultimate completion date of January 30, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,023.56 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for PREVNAR 20 vaccine syringes (0.5ML). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of May 9, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8D7TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,581.94 to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5mL) on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. Prevnar 20, a pneumococcal vaccine, represents one category of vaccines and specialty pharmaceuticals the company provides through its extensive federal contract portfolio. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans to make multiple regional awards, with AmerisourceBergen positioned as a key supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/20/25 |